Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: Assessing specificity and affinity

Structure

Volumn 4, Issue 11, 1996, Pages 1317-1324

  Rutenber, Earl E ^a   Stroud, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anti cancer drug; folate analog; protein ligand interaction; structure based drug design; ZD1694

Indexed keywords

ESCHERICHIA COLI;

EID: 0030589168     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00139-6     Document Type: Article

References (28)

1. Hartman, K.R. & Heidelberger, C. (1958). Studies on fluorinated pyrimidines: XIII. Inhibition of thymidylate synthase. J. Biol. Chem. 236, 3006-3016.
2. Heidelberger, C. (1965). Fluorinated pyrimidines. Prog. Nucleic Acid Res. Mol. Biol. 4, 1-50.
3. Jones, T.R., et al., & Harrap, K.R. (1981). A potent antitumor quinazoline inhibitor of thymidylate synthase: synthesis, biological properties and therapeutic results in mice. Eur. J. Cancer 17, 11-19.
4. Jackson, R.C., Jackman, A.L. & Calvert, A.H. (1983). Biochemical effects of a quinazoline inhibitor of thymidylate synthase, CB3717, on human lymphoblastoid cells. Biochem. Pharmacol. 32, 3783-3790.
5. Jackman, A.L., et al., & Calvert, A.H. (1990). Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo. Cancer Res. 50, 5212-5218.
6. Alison, D.L., et al., & Calvert, A.H. (1985). The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB3717). Cancer Chemother. Pharmacol. 14, 265-271.
7. Newell, D.R., et al., & O'Connor, P. (1986). Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. Cancer Treat. Rep. 70, 971-979.
8. Jackman, A.L., et al., & Stephens, T.C. (1991). ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 51, 5579-5586.
9. Cunningham, D., et al., & Perez-Manga, G. (1995). 'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The Tomudex' Colorectal Cancer Study Group. Eur. J. Cancer A 31, 1945-1954.
10. Marsham, P.R., et al., & Calvert, A.H. (1991). Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications J. Med. Chem. 34, 1594-1605.
11. Montfort, W.R., et al., & Stroud, R.M. (1990). Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry 29, 6964-6977. [Published erratum appears in Biochemistry (1990) 29, 10864].
12. Fauman, E.B., Rutenber, E.E., Maley, G.F., Maley, F. & Stroud, R.M. (1994). Water-mediated substrate/product discrimination: the product complex of thymidylate synthase at 1.83 Å Biochemistry 33, 1502-1511.
13. Matthews, D.A., et al., & Freer, S. (1990). Stereochemical mechanism of action for thymidylate synthase based on the X-ray structure of the covalent inhibitory ternary complex with 5-fluoro-2-·deoxyuridylate and 5,10-methylenetetrahydrofolate. J. Mol. Biol. 214, 937-948.
14. Matthews, D.A., Appelt, K., Oatley, S.J. & Xuong, N.H. (1990). Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2·-deoxyuridylate and 10-propargyl-5,8-dideazafolate. J. Mol. Biol. 214, 923-936.
15. Kamb, A., Finer-Moore, J.S. & Stroud, R.M. (1992). Cofactor triggers the conformational change in thymidylate synthase: implications for an ordered binding mechanism. Biochemistry 31, 12876-12884.
16. Kamb, A., Finer-Moore, J., Calvert, A.H. & Stroud, R.M. (1992). Structural basis for recognition of polyglutamyl folates by thymidylate synthase. Biochemistry 31, 9883-9890.
17. Perry, K.M., et al., & Stroud, R.M. (1990). Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. Proteins 8, 315-333.
18. Stroud, R.M. & Fauman, E.B. (1995). Significance of structural changes in proteins: expected errors in refined protein structures. Protein Sci. 4, 2392-2404.
19. Stroud, R.M. & Finer-Moore, J.S. (1993). Stereochemistry of a multistep/bipartite methyl transfer reaction: thymidylate synthase. FASEB J. 7, 671-677.
20. Carreras, C.W. & Santi, D.V. (1995). The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem. 64, 721-762.
21. Maley, G.F. & Maley, F. (1988). Properties of a defined mutant of Escherichia coli thymidylate synthase. J. Biol. Chem. 263, 7620-7627.
22. Brünger, A.T. (1992). X-PLOR Version 3.1. A system for X-ray crystallography and NMR, Yale University Press, New Haven and London.
23. Jones, T.A. (1985). Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. Methods. Enzymol. 115, 157-171.
24. Brünger, A.T. (1988). Crystallographic refinement by simulated annealing. Application to a 2.8 Å resolution structure of aspartate aminotransferase. J. Mol. Biol. 203, 803-816.
25. Huang, C.C., Pettersen, E.F., Klein, T.E., Ferrin, I.E. & Langridge, R. (1991). Conic: a fast renderer for space-filling molecules with shadows. J. Mol. Graphics 9, 230-236.
26. Ferrin, T.E., Huang, C.C., Jarvis, L.E. & Langridge, R. (1988). The MIDAS Display System. J. Mol. Graphics 6, 13-37.
27. Sack, J. (1988). CHAIN - A Crystallographic modeling program. J. Mol. Graphics 6, 244-245.
28. Wallace, A.C., Laskowski, R.A. & Thornton, J.M. (1995). LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134.